Filtered By:
Infectious Disease: Coronavirus

This page shows you your search results in order of relevance. This is page number 2.

Order by Relevance | Date

Total 2387 results found since Jan 2013.

Drug allergy labeling and delabeling in the coronavirus disease 2019 era
At the time of this writing, April 7, 2020, more than 1.2 million people worldwide are infected and more than 68,000 have died because of coronavirus disease 2019 (COVID-19) induced by the novel severe acute respiratory syndrome coronavirus 2 infection, and this figure will surely multiply in the next few weeks according to Dr Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases. Severe acute respiratory syndrome coronavirus 2 uses angiotensin-converting enzyme-2 (ACE-2) (a type I transmembrane metallocarboxypeptidase) as its preferred entry receptor.
Source: Annals of Allergy, Asthma and Immunology - May 22, 2020 Category: Allergy & Immunology Authors: Mariana C. Castells Tags: Editorial Source Type: research

Patient Satisfaction with Telemedicine Encounters in an Allergy/Immunology Practice During the COVID-19 Pandemic
The use of telemedicine dates as far back as 50 years ago, when the University of Nebraska used interactive telemedicine to transmit neurologic examinations.1 Since that time, despite advances in available technologies, and proven utility of telemedicine in allergy/immunology (AI),2,3 the uptake of telemedicine by AI physicians remains low.4 With the global spread of novel coronavirus disease 2019 (COVID-19), AI physicians were abruptly forced to change their mode of health care delivery. Given the need for social distancing and exposure mitigation, many practices quickly adapted to remote encounters from primarily in-person care.
Source: Annals of Allergy, Asthma and Immunology - June 20, 2020 Category: Allergy & Immunology Authors: S. Shahzad Mustafa, Luanna Yang, Mahta Mortezavi, Karthik Vadamalai, Allison Ramsey Tags: Letters Source Type: research

Patient satisfaction with telemedicine encounters in an allergy and immunology practice during the coronavirus disease 2019 pandemic
The use of telemedicine dates as far back as 50 years ago, when the University of Nebraska used interactive telemedicine to transmit neurologic examinations.1 Since that time, despite advances in available technologies and proven utility of telemedicine in allergy and immunology (AI),2,3 the use of telemedicine by AI physicians remains low.4 With the global spread of the novel coronavirus disease 2019 (COVID-19), AI physicians were abruptly forced to change their mode of health care delivery. Given the need for social distancing and exposure mitigation, many practices quickly adapted to remote encounters from primarily in-person care.
Source: Annals of Allergy, Asthma and Immunology - June 20, 2020 Category: Allergy & Immunology Authors: S. Shahzad Mustafa, Luanna Yang, Mahta Mortezavi, Karthik Vadamalai, Allison Ramsey Tags: Letters Source Type: research

Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists.
CONCLUSION: In light of these unprecedented times, the need to understand the nuances of these viral respiratory pathogens, especially SARS-CoV-2, cannot be overemphasized. This knowledge base is of particular importance to otolaryngologists, whose expertise in the upper airway coincides with the anatomic tropism of these infectious agents. PMID: 32762250 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - August 5, 2020 Category: ENT & OMF Authors: Yuen E, Gudis DA, Rowan NR, Nguyen SA, Schlosser RJ Tags: Am J Rhinol Allergy Source Type: research

A Systematic Review of the Neuropathologic Findings of Post-Viral Olfactory Dysfunction: Implications and Novel Insight for the COVID-19 Pandemic.
CONCLUSIONS: The mechanism of post-viral olfactory dysfunction is highly complex, virus-dependent, and involves a combination of insults at multiple levels of the olfactory pathway. This will have important implications for future diagnostic and therapeutic developments for patients infected with COVID-19. PMID: 32915650 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - September 10, 2020 Category: ENT & OMF Authors: Lee JC, Nallani R, Cass L, Bhalla V, Chiu AG, Villwock JA Tags: Am J Rhinol Allergy Source Type: research

Impact of COVID-19 Pandemic on Ambulatory and Operating Room Rhinology Practice in the US.
CONCLUSION: COVID-19 has drastically affected rhinologic practice. There is a dramatic reduction of in person care in the office setting and surgical management of sinonasal and skull base disease. Enhanced PPE is being used in only half of potentially aerosolizing procedures which represents an area of further education. Novel approaches such as use of virtual encounters and point of care testing should be considered as options to facilitate care. PMID: 33019817 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - October 4, 2020 Category: ENT & OMF Authors: Papagiannopoulos P, Ganti A, Kim YJ, Raad RA, Kuan EC, Losavio P, Tajudeen BA, Batra PS Tags: Am J Rhinol Allergy Source Type: research

Quantification of Aerosol Particle Concentrations During Endoscopic Sinonasal Surgery in the Operating Room.
CONCLUSION: Drilling and microdebrider use during endonasal surgery in a standard operating room is associated with a significant increase in airborne particle concentrations. Fortunately, this increase in aerosol concentration is localized to the area of the operating surgeon, with no detectable increase in aerosol particles at other OR positions. PMID: 33012174 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - October 3, 2020 Category: ENT & OMF Authors: Murr A, Lenze NR, Brown WC, Gelpi MW, Ebert CS, Senior BA, Thorp BD, Zanation AM, Kimple AJ Tags: Am J Rhinol Allergy Source Type: research

Urticaria and coronavirus infection: a lesson from SARS-CoV-2 pandemic.
Authors: Allegra A, Asero R, Giovannetti A, Isola S, Gangemi S Abstract Summary: Urticaria is a condition involving both skin and mucosal tissues characterized by the presence of wheals and/or angioedema. The acute form has been related to allergic reactions to drugs or foods, interaction with chemicals, or infections. We reviewed the association of urticaria with coronavirus infections. This review was carried out by the use of two search engines for published original articles, employing two key terms correlated to urticaria and viruses: "urticaria" and one term linked to each virus. The research of the relations...
Source: European Annals of Allergy and Clinical Immunology - October 11, 2020 Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research

High anxiety and health-related quality of life in families with children with food allergy during coronavirus disease 2019
Food allergy has a known effect on quality of life (QoL), but this has not been extensively studied during the coronavirus disease 2019 pandemic.
Source: Annals of Allergy, Asthma and Immunology - September 17, 2020 Category: Allergy & Immunology Authors: Jennifer L.P. Protudjer, Michael Golding, Marlee R. Salisbury, Elissa M. Abrams, Leslie E. Roos Source Type: research

What do asthmatic patients think about telemedicine visits?
Discussion and conclusions. Our survey revealed that small changes could further increase patients' satisfaction, adherence, and confidence in telemedicine. Although presenting some limitations, virtual visits seem to be generally well accepted by asthmatic patients and it might be a good alternative for in-person visits, at least in such difficult times when social distancing is recommended. PMID: 33191719 [PubMed - as supplied by publisher]
Source: European Annals of Allergy and Clinical Immunology - November 17, 2020 Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research

COVID-19 Associated Multisystem Inflammatory Syndrome: A Systematic Review and Meta-analysis.
This study was aimed to describe clinical manifestation and outcomes of MIS-C associated with COVID-19. This systematic review and meta-analysis were conducted on all available literature until July 3rd, 2020. The screening was done by using the following keywords: ("novel coronavirus" Or COVID-19 or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus) and ("MIS-C" or "multisystem inflammatory" or Kawasaki). Data on gender, ethnicity, clinical presentations, need for mechanical ventilation or admission to intensive care unit (ICU), imaging, cardiac complications, and COVID-19 laboratory results were...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 19, 2020 Category: Allergy & Immunology Authors: Baradaran A, Malek A, Moazzen N, Abbasi Shaye Z Tags: Iran J Allergy Asthma Immunol Source Type: research

Procalcitonin Has Good Accuracy for Prognosis of Critical Condition and Mortality in COVID-19: A Diagnostic Test Accuracy Systematic Review and Meta-analysis.
Abstract Several reports have determined that changes in white blood cell counts and inflammatory biomarkers are related to disease outcome of coronavirus disease 2019 (COVID-19) and they can be utilized as prognostic biomarkers. For introducing a factor as a diagnostic/prognostic biomarker, diagnostic test accuracy (DTA) systematic review and meta-analysis are recommended. For the first time, we aimed to determine the accuracies of white blood cell counts and inflammatory biomarkers for prognosis of COVID-19 patient's outcome by a DTA meta-analysis. Until August24, 2020, we searched Web of Sciences, Scopus, and M...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 19, 2020 Category: Allergy & Immunology Authors: Zare ME, Wang Y, Nasir Kansestani A, Almasi A, Zhang J Tags: Iran J Allergy Asthma Immunol Source Type: research

Prevalence of SARS-CoV-2 in Patients with Severe Pneumonia in Khuzestan Province, Iran.
This study aimed to evaluate the frequency of SARS-CoV-2 in hospitalized patients with an acute respiratory infection (ARI). During an outbreak of the SARS-CoV-2, the nasopharyngeal and oropharyngeal swabs were collected from 909 hospitalized patients with severe pneumonia, including 517 (56.9%) males and 392 (43.1%) females. All the collected samples were from different cities of Khuzestan province from 19 February to- 27 March 2020. The RNA was extracted from samples and subjected to real-time polymerase chain reaction (PCR) tests for the detection of the SARS-CoV-2. Simultaneously, the computerized tomography (CT) scan ...
Source: Iranian Journal of Allergy, Asthma and Immunology - October 18, 2020 Category: Allergy & Immunology Authors: Abolnezhadian F, Makvandi M, Alavi SM, Azaran A, Jalilian S, Rashno M, Kaydani GA, Arshadi M, Hosseinizadeh SM, Boostani H, Seyedian SS, Moogahi S, Salmanzadeh S, Varnaseri M, Neisi N, Keifarrokhi H, Shariati G, Amiri H, Parsanahad M, Nashibi R, Yousefi F Tags: Iran J Allergy Asthma Immunol Source Type: research

Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.
Abstract The new coronavirus, known as "SARS-CoV-2"; is the cause of one of the most prevalent infectious viral diseases that was recently announced pandemic by the world health organization. Ongoing research in the fields of prevention, management, and therapy establishes a functional scaffold for clinics during the time of crisis. To obtain this goal, it is necessary that all pathophysiologic aspects of COVID-19 from infection to predisposing backgrounds of infection be identified, so that all the ambiguities of researchers regarding transmission mechanisms, variable clinical manifestation, and therapeutic respo...
Source: Iranian Journal of Allergy, Asthma and Immunology - October 18, 2020 Category: Allergy & Immunology Authors: Imani-Saber Z, Vaseghi H, Mahdian M, Safari F, Ghadami M Tags: Iran J Allergy Asthma Immunol Source Type: research

Asthma in patients with coronavirus disease 2019: a systematic review and meta-analysis.
CONCLUSION: The pooled prevalence of asthma in COVID-19 patients was similar to that in the general population, and asthma might be an independent protective factor for the death of COVID-19 patients, which suggests that we should pay high attention to COVID-19 patients with asthma and take locally tailored interventions and treatment. Further well-designed studies with large sample sizes are required to verify our findings. PMID: 33609770 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - February 17, 2021 Category: Allergy & Immunology Authors: Shi L, Xu J, Xiao W, Wang Y, Jin Y, Chen S, Duan G, Yang H, Wang Y Tags: Ann Allergy Asthma Immunol Source Type: research